GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Indo-Bangla Pharmaceuticals Ltd (DHA:IBP) » Definitions » FCF Margin %

Indo-Bangla Pharmaceuticals (DHA:IBP) FCF Margin % : 0.00% (As of . 20)


View and export this data going back to 2018. Start your Free Trial

What is Indo-Bangla Pharmaceuticals FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Indo-Bangla Pharmaceuticals's Free Cash Flow for the six months ended in . 20 was BDT0.00 Mil. Indo-Bangla Pharmaceuticals's Revenue for the six months ended in . 20 was BDT0.00 Mil. Therefore, Indo-Bangla Pharmaceuticals's FCF Margin % for the quarter that ended in . 20 was 0.00%.

As of today, Indo-Bangla Pharmaceuticals's current FCF Yield % is 0.00%.

The historical rank and industry rank for Indo-Bangla Pharmaceuticals's FCF Margin % or its related term are showing as below:


DHA:IBP's FCF Margin % is not ranked *
in the Drug Manufacturers industry.
Industry Median: 0.86
* Ranked among companies with meaningful FCF Margin % only.


Indo-Bangla Pharmaceuticals FCF Margin % Historical Data

The historical data trend for Indo-Bangla Pharmaceuticals's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Indo-Bangla Pharmaceuticals FCF Margin % Chart

Indo-Bangla Pharmaceuticals Annual Data
Trend
FCF Margin %

Indo-Bangla Pharmaceuticals Semi-Annual Data
FCF Margin %

Competitive Comparison of Indo-Bangla Pharmaceuticals's FCF Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Indo-Bangla Pharmaceuticals's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Indo-Bangla Pharmaceuticals's FCF Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Indo-Bangla Pharmaceuticals's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Indo-Bangla Pharmaceuticals's FCF Margin % falls into.


;
;

Indo-Bangla Pharmaceuticals FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Indo-Bangla Pharmaceuticals's FCF Margin for the fiscal year that ended in . 20 is calculated as

FCF Margin=Free Cash Flow (A: . 20 )/Revenue (A: . 20 )
=/
= %

Indo-Bangla Pharmaceuticals's FCF Margin for the quarter that ended in . 20 is calculated as

FCF Margin=Free Cash Flow (Q: . 20 )/Revenue (Q: . 20 )
=/
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Indo-Bangla Pharmaceuticals FCF Margin % Related Terms

Thank you for viewing the detailed overview of Indo-Bangla Pharmaceuticals's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Indo-Bangla Pharmaceuticals Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
Ahmed Akbar Sobhan Road, Block B, Plot No. 183, 6th Floor, Bashundhara R/A, Baridhara, Dhaka, BGD, 1229
Indo-Bangla Pharmaceuticals Ltd is engaged in the manufacturing, marketing, and distribution of generic pharmaceutical products. The products of the company include human drugs dosages form such as tablets, capsules, syrup, oral saline, and suspension. The products of the company are sold in the domestic market.